Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures

NCT00309335 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia, Dental

Interventions

DRUG: Phentolamine Mesylate (NV-101)

Sponsor

Novalar Pharmaceuticals, Inc.